CLINICAL_TRIALS
trial_result
· 2018-10-09
Clinical Trial Update: A Study of Evacetrapib (LY2484595) in Japanese Participants With Primary Hypercholesterolemia [Phase 3]
Summary
Phase 3 trial of evacetrapib in Japanese participants with primary hypercholesterolemia was terminated; results posted in 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Hypercholesterolemia | Phase 3 | Status: TERMINATED | Results posted: 2018-10-09